ABSTRACT
In the present study, the possible role of a potent cannabinoid agonist, WIN55, 212-2 in the dorsal hippocampus on pain and memory performance has been evaluated. Animals were cannulated in CA1 region of the hippocampus using sterotaxic apparatus. Ten days after recovery, animals were trained in passive avoidance learning (PAL), and immediately received different doses of WIN 55212-2 (0.1, 0.25 and 0.5µg/rat), and were tested 24 h after the training. In the second part of the experiment animals received either WIN 55212-2 (0.5µg/rat) or saline respectively. Tail flick latency was measured three times with 10 minutes interval 30 minutes and 24 hours after the infusion into the CA1. Results indicate that post-training intra-CA1 administration of WIN55, 212-2 (0.25 and 0.5µg/rat).